Bernardo A. Pons‐Estel

Author

Also Known As

B A Pons-Estel, B Pons Estel, B Pons-Estel, B. A. Pons-Estel, B. P. Tsao, B. Pons-Estel, B. PonsEstel, B.A. Pons-Estel, BA Pons-Estel, BERNARDO A. PONS-ESTEL

297

Publications

13.4K

Citations

H-Index

Concepts

All Affiliations

Hospital Provincial de Rosario University of Alabama at Birmingham Centro Científico Tecnólogico - Rosario Oklahoma Medical Research Foundation Uppsala University

About

Bernardo A. Pons‐Estel is an author at Hospital Provincial de Rosario specializing in medicine, autoimmune disease, and lupus.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	37	4.4K
2	Public Health	14	16	962
3	Natural Sciences	2	2	134
4	Health Sciences	1	1	18
5	Social Sciences	1	1	126

Bernardo A. Pons‐Estel

106

Publications

11.1K

Citations

H-Index

Page 1

	Year	Citations
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Annals of the Rheumatic Diseases	2023	766
A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus Robert Graham, Sergey V. Kozyrev, Emily C. Baechler, Nature Genetics Common HaplotypeAutoimmune DiseaseSystemic Lupus ErythematosusLupusGenetics	2006	668
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, The Lancet Respiratory Medicine Autoimmune DiseaseSystemic SclerodermaImmunologySystemic SclerosisMultiple Sclerosis	2020	612
The GLADEL Multinational Latin American Prospective Inception Cohort of 1,214 Patients With Systemic Lupus Erythematosus Bernardo A. Pons‐Estel, Luís J. Catoggio, Mario H. Cardiel, Medicine Autoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus TreatmentLupusLupus Nephritis	2004	436
Transancestral mapping and genetic load in systemic lupus erythematosus Carl D. Langefeld, Hannah C. Ainsworth, Deborah S. Cunninghame Graham, Nature Communications	2017	420
Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort D Alarcón-Segovia, Marta E. Alarcón‐Riquelme, Mario H. Cardiel, Arthritis & Rheumatism	2005	417
Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate‐naive patients with active rheumatoid arthritis: Twenty‐four–week results of a phase III, multicenter, randomized, double‐blind, placebo‐controlled study of golimumab before methotrexate as first‐line therapy for early‐onset rheumatoid arthritis Paul Emery, Roy Fleischmann, Larry W. Moreland, Arthritis & Rheumatism	2009	393
The Tumor-Necrosis-Factor Receptor–Associated Periodic Syndrome: New Mutations in TNFRSF1A, Ancestral Origins, Genotype-Phenotype Studies, and Evidence for Further Genetic Heterogeneity of Periodic Fevers Ivona Aksentijevich, Jérôme Galon, Miguel Luz Soares, The American Journal of Human Genetics InflammationPeriodic FeversAutoimmune DiseaseAncestral OriginsDisease Mechanism	2001	335
2021 DORIS definition of remission in SLE: final recommendations from an international task force Ronald van Vollenhoven, George Βertsias, Andrea Doria, Lupus Science & Medicine	2021	299
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus Indra Adrianto, Feng Wen, Amanda Templeton, Nature Genetics InflammationRheumatologyAutoimmune DiseaseSystemic Lupus ErythematosusFunctional Variant Downstream	2011	282

Page 1